Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
AstraZeneca shares leap with FDA set to review drug to treat breast cancer
10:54am, Wednesday, 01'st Oct 2025
AstraZeneca shares rallied on Wednesday after the U.K. giant and its Japanese partner said the Food and Drug Administration was reviewing one of its drugs to treat breast cancer.
AstraZeneca and other UK pharma boosted by Trump's first drug discount deal with Pfizer
03:29am, Wednesday, 01'st Oct 2025
Shares in the UK's biggest drug companies led the way on Wednesday, following news overnight that the US government had agreed its first deal on "most favoured nation" drug pricing with Pfizer. Toppi
CNBC's UK Exchange newsletter: AstraZeneca gets a shot on Wall Street
01:30am, Wednesday, 01'st Oct 2025
AstraZeneca is delisting its American Depositary Receipts from the Nasdaq, replacing them with a direct listing of ordinary shares on the New York Stock Exchange. At first blush, it confirms fears f
AstraZeneca's US listing may pull other firms from London in its wake
10:29am, Tuesday, 30'th Sep 2025
AstraZeneca's move to upgrade its listing in the U.S. risks pulling liquidity away from London's stock market and could pave the way for other large companies to follow suit, analysts, investors and a
Pharma giant AstraZeneca eyes NYSE listing overhaul, keeps London base
10:02am, Tuesday, 30'th Sep 2025
AstraZeneca announced plans to change how it lists shares in the United States by moving from American depositary receipts (ADRs) on Nasdaq to a direct listing of its ordinary shares on the New York S
AstraZeneca plans to list on NYSE, but will remain in the U.K.
02:52pm, Monday, 29'th Sep 2025
AstraZeneca laid out plans on Monday to switch to a direct listing of its shares in the United States, as the drugmaker seeks to maximise gains from a booming U.S. stock market, even as it said it was
AstraZeneca's New York listing tweak dubbed a 'knock-back for London'
08:17am, Monday, 29'th Sep 2025
Shares in AstraZeneca PLC (LSE:AZN) rose on Monday as it shared plans to directly list its shares on the New York Stock Exchange instead of American depository shares (ADSes). The FTSE 100 pharmaceu
Pharma giant AstraZeneca eyes NYSE listing overhaul, keeps London base
04:43am, Monday, 29'th Sep 2025
AstraZeneca announced plans to change how it lists shares in the United States by moving from American depositary receipts (ADRs) on Nasdaq to a direct listing of its ordinary shares on the New York S
AstraZeneca to directly list shares in New York, retain UK listing
02:07am, Monday, 29'th Sep 2025
AstraZeneca said on Monday that it will now directly list its shares on the New York Stock Exchange, instead of the current depository shares, adding that it will continue to be listed and headquarter
3 Magnificent Stocks Under $100 to Buy Right Now
06:45am, Saturday, 27'th Sep 2025
Share price has nothing to do with whether a stock is fairly valued. However, it is nonetheless an important consideration for investors on tight budgets.
A New Prescription For Pain: Understanding Trump's 100% Pharma Tariff
02:37pm, Friday, 26'th Sep 2025
Novo Nordisk, Sanofi, and AstraZeneca face the largest dollar exposure to President Trump's new 100% tariff on imported branded drugs. NVO's heavy reliance on U.S. sales and imported GLP-1 products pu
AstraZeneca to Offer Discounted Drugs As Trump Pressures Pharma Industry to Cut Prices
11:43am, Friday, 26'th Sep 2025
AstraZeneca said it will offer its asthma and diabetes drugs at an up to 70% discount in the U.S. ahead of a Trump administration deadline for pharmaceutical companies to cut drug prices.
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces the launch of AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access their pr
AstraZeneca to cut some direct-to-patient US drug prices after Trump demand
08:53am, Friday, 26'th Sep 2025
AstraZeneca said on Friday it will sell its diabetes and asthma drugs direct to cash-paying U.S. patients at a discount of up to 70% off list prices, the latest pharma company to do so after pressure
Astrazeneca (AZN) Declines More Than Market: Some Information for Investors
07:16pm, Thursday, 25'th Sep 2025
The latest trading day saw Astrazeneca (AZN) settling at $73.53, representing a -2.43% change from its previous close.
